Amino-terminal identity of co-existent amyloid and non-amyloid immunoglobulin K light chain deposits. A human disease to study alterations of protein conformation

Clinical and Experimental Immunology

Volumn 110, Issue 3, 1997, Pages 472-478

  Kaplan, B ^b   Vidal, R ^a   Kumar, A ^a   Ghiso, J ^a   Frangione, B ^a   Gallo, Gloria ^a,c  

^a NEW YORK UNIVERSITY   (United States)

^b HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gammopathy; Monoclonal immunoglobulins; Protein conformation

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; PARAPROTEIN;

AGED; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; GAMMOPATHY; GLOMERULUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN CONFORMATION; RENAL ARTERY;

EID: 0030783302     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4421454.x     Document Type: Article

References (29)

1. Ganeval D, Noel LH, Preud'homme JL et al. Light-chain deposition disease: its relation with AL-type amyloidosis. Kidney Int 1984; 26:1- 9.
2. Gallo G, Picken M, Buxbaum J et al. The spectrum of monoclonal immunoglobulin deposition diseases associated with immunocytic dyscrasias. Semin Hematol 1989; 26:234-45.
3. Jacquot C, Saint-Andre JP, Touchard G et al. Association of systemic light chain deposition disease and amyloidosis: a report of three patients with renal involvement. Clin Nephrol 1985; 24:93-98.
4. Kirkpatrick CJ, Curry A, Galle J et al. Systemic kappa light chain deposition and amyloidosis in multiple myeloma: novel morphologic observations. Histopathology 1986; 10:1065-76.
5. Smith NM, Malcolm AJ. Simultaneous AL-type amyloid and light chain deposit disease in a liver biopsy: a case report. Histopathology 1986; 10:1057-64.
6. Gallo G, Picken M, Frangione B et al. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component. Mod Pathol 1988; 1:453-6.
7. Sanders PW, Herrera GA, Kirk KA et al. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab Invest 1991; 64:527-37.
8. Ivanyi B, Varga G, Nagy J et al. Light chain deposition nephropathy in necropsy material. Zentralbl Pathol 1991; 137:366-71.
9. Faa G, Van Eyken P, De Vos R et al. Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. A case report and literaure review. J Hepatol 1991; 12:75-82.
10. Lam KY, Chan KW. Unusual findings in a myeloma kidney: a light and electron microscopic study. Nephron 1993; 65:133-6.
11. Strom EH, Fogazzi GB, Banfi G et al. Light chain deposition disease of the kidney. Morphological aspects in 24 patients. Virchow Arch 1994; 425:271-80.
12. Vidal R, Garzuly F, Budka H et al. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD18G). Am J Pathol 1996; 148:361-6.
13. Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol 1996; 148:351-4.
14. Ghiso J, Wisniewski T, Frangione B. Unifying features of systemic and cerebral amyloidosis. Molec Neurobiol 1994; 8:49-64.
15. Solomon A, Frangione B, Franklin HS. Bence Jones proteins and light chains of immunoglobulin. Preferential association of the Vλ VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest 1982; 70:453-60.
16. Kabat EA, Wu TT, Perry MM et al. Human κ light chain subgroup I. Sequences of proteins of immunological interest. Bethesda: National Institutes of Health. 1991:103-12.
17. Soto C, Kindy S, Baumann M et al. Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem Biophys Res Commun 1996; 226:672-80.
18. Ghanta J, Shen C-L, Kiessling LL et al. A strategy for designing inhibitors of β-amyloid toxicity. J Biol Chem 1996; 271:29525-8.
19. Kaplan B, German G, Pras M. Isolation and characterization of amyloid proteins from milligram amounts of amyloid-containing tissue. J Liq Chromatogr 1993; 16:249-68.
20. Gallo G, Wiesniewski T, Choi-Miura N-H et al. Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol 1994; 145:525-30.
21. Yang CH, Gallo GR. Protein A-gold immunoelectron microscopic study of amyloid fibrils, granular deposits, and fibrillar luminal aggregates in renal amyloidosis. Am J Pathol 1990; 137:1223-31.
22. Krakawer C, Greenspon SA. Localization of nephrotoxic antigen within isolated renal glomerulus. AMA Arch Pathol 1951; 51:629-39.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
25. Matsudaira P. Sequence from picomole quantities of proteins electro-blotted on to polyvinylidine difluoride membranes. J Biol Chem 1987; 262:10035-8.
26. Tagliavini F, Giacconne G, Frangione B et al. Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett 1988; 93:191-6.
27. Soto C, Frangione B. Two conformational states of amyloid β-peptide: implication for the pathogenesis of Alzheimer's disease. Neurosci Lett 1995; 186:115-8.
28. Huang Z, Prusiner SB, Cohen FE. Scrappie prions: a three-dimensional model of an infectious fragment. Folding & Design 1996; 1:13-19.
29. Wisniewski HM, Wegiel J, Wang KC et al. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 1992; 84:117-27.